Onconetix, Inc. (NASDAQ:ONCO), a pharmaceutical company with a market capitalization of $4.48 million, has reached a settlement agreement with IQVIA, Inc., a provider of advanced analytics ...

06:17 EST Onconetix (ONCO) files to sell 50M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now ...

Onconetix, Inc., a pharmaceutical preparations company with a market capitalization of $4.48 million, has entered into a material definitive agreement and created a direct financial obligation ...

Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on December 6, 2024 indicating that the Company’s failure to ...

Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on December 6 ...

Onconetix, Inc., a pharmaceutical preparations company with a market capitalization of $4.48 million, has entered into a material definitive agreement and created a direct financial obligation, ...

Onconetix, Inc. (NASDAQ:ONCO), a pharmaceutical company with a market capitalization of $4.48 million, has reached a settlement agreement with IQVIA, Inc., a provider of advanced analytics, technology ...